Position in DMRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$63,221,900
New position
Shares Held
2,441,000
first reported quarter
Ownership
3.97%
of shares outstanding
% of Portfolio
8.84%
of 13F equity value
Holder Rank
#5
of 65 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026FCPM III SERVICES B.V. holds $714,925,124 across 9 Biotechnology names. DMRA ranks #6 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,198,900 | $294,456,788 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
4,644,386 | $84,202,718 | |
| 3 | VOR |
Vor Biopharma Inc.
|
4,117,354 | $73,453,595 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
9,632,561 | $65,597,740 | |
| 5 | MPLT |
MapLight Therapeutics, Inc.
|
3,226,400 | $65,592,712 | |
| 6 | DMRA |
Damora Therapeutics, Inc.
This page
|
2,441,000 | $63,221,900 | |
| 7 | CBIO |
Crescent Biopharma, Inc.
|
1,677,852 | $30,822,141 | |
| 8 | REPL |
Replimune Group, Inc.
|
2,808,368 | $21,484,015 |
All Filings in DMRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,221,900 | 2,441,000 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||